| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the * Laboratory of Pharmaceutics, Gifu
Pharmaceutical University, Mitahora-higashi, Gifu, Japan;
Department of Urologic Surgery, Vanderbilt
University Medical Center, Nashville, Tennessee; and the
Department of Urology, Mie University School
of Medicine, Edobashi, Tsu, Mie, Japan.
| Correspondence to: Dr Kazuyuki Hirano, Laboratory of Pharmaceutics, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu 502-8585, Japan (e-mail: hirano{at}gifu-pu.ac.jp). |
Key words: Hormone-refractory, metallothionein, ZnT1, ZnT3
This article has been cited by other articles:
![]() |
K. Ishii, T. Imamura, K. Iguchi, S. Arase, Y. Yoshio, K. Arima, K. Hirano, and Y. Sugimura Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo Endocr. Relat. Cancer, June 1, 2009; 16(2): 415 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dubi, L. Gheber, D. Fishman, I. Sekler, and M. Hershfinkel Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells Carcinogenesis, September 1, 2008; 29(9): 1692 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iguchi, K. Ishii, T. Nakano, T. Otsuka, S. Usui, Y. Sugimura, and K. Hirano Isolation and Characterization of LNCaP Sublines Differing in Hormone Sensitivity J Androl, September 1, 2007; 28(5): 670 - 678. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |